| Literature DB >> 25389528 |
Kai O Hensel1, Andreas Jenke2, Roman Leischik3.
Abstract
Early diagnosis of cardiac alterations in hypertensive heart disease is still challenging. Since such patients might have depressed global LV systolic strain or strain rate when EF is still normal, speckle-tracking echocardiography (STE) and tissue-Doppler imaging (TDI) combined with stress echocardiography might improve early diagnosis of cardiac alterations. In this prospective study standard 2D Doppler echocardiography, STE, and TDI were performed at rest and during bicycle exercise in 92 consecutive patients--46 hypertensive subjects with normal ejection fraction and 46 healthy controls. STE and TDI were used to measure global peak systolic LV circumferential strain (CS), longitudinal strain (LS), and longitudinal strain rate (SR). Mean arterial blood pressure was significantly higher in hypertensive patients at rest (100.8 mmHg SD 13.5 mmHg; P=0.002) and during physical exercise testing (124.2 mmHg SD 13.4 mmHg; P=0.003). Hypertensive patients had significantly reduced values of systolic CS (P=0.001), LS (P=0.014), and SR (P<0.001) at rest as well as during physical exercise-CS (P<0.001), LS (P<0.001), and SR (P<0.001). Using STE and TDI, reduced LV systolic strain and strain rate consistent with early cardiac alterations can be detected in patients with arterial hypertension. These findings were evident at rest and markedly pronounced during exercise echocardiography.Entities:
Mesh:
Year: 2014 PMID: 25389528 PMCID: PMC4214170 DOI: 10.1155/2014/472562
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Antihypertensive therapy regimen in the study group; control subjects were under no influence of antihypertensive medication.
| Hypertensive Patients ( | |
|---|---|
| Behavioural/nutritional management only | 14 |
| Beta-Blocker | 9 |
| ACE-/AT1-Inhibitor | 7 |
| Beta-Blocker and ACE-/AT1-Inhibitor | 9 |
| Beta-Blocker, ACE-/AT1-Inhibitor and Ca-Antagonist | 7 |
Clinical characterisitcs of the entire study population and sub-group analysis, P-values: Mann-Whitney-U-Test, Fischer's exact test.
| All subjects ( | ||||
|---|---|---|---|---|
| Hypertensive ( | Control ( |
| ||
| Sex | 22 F, 24 M | 25 F, 21 M | NS | |
| Age (years) | 46.6 SD 14.4 | 44 SD 22.5 | NS | |
| Height (cm) | 174 SD 10.2 | 172.9 SD 9.2 | NS | |
| Weight (kg) | 86 SD 21.4 | 70.8 SD 11.9 | 0.000 | |
| BMI | 28.5 SD 7.6 | 23.6 SD 3 | 0.000 | |
| BSA (m2) | 2 SD 0.2 | 1.8 SD 0.2 | 0.001 | |
|
| ||||
| At rest | Systolic BP (mmHg) | 131 SD 20.5 | 121.7 SD 16.7 | 0.043 |
| Diastolic BP (mmHg) | 85.7 SD 13.5 | 78.8 SD 10.8 | 0.011 | |
| Mean BP (mmHg) | 100.8 SD 13.5 | 93.1 SD 10.5 | 0.002 | |
| Heart rate (bpm) | 69.3 SD 11.8 | 72.4 SD 15.1 | NS | |
| EF (%) | 56.3 SD 7.6 | 57.2 SD 7.2 | NS | |
|
| ||||
| 50 W | Systolic BP (mmHg) | 152.0 SD 19.9 | 147.9 SD 19 | NS |
| Diastolic BP (mmHg) | 90.1 SD 12.2 | 80.5 SD 11.3 | 0.000 | |
| Mean BP (mmHg) | 110.7 SD 11.6 | 103 SD 10.2 | 0.000 | |
| Heart rate (bpm) | 107.4 SD 13.2 | 113.2 SD 16 | NS | |
| EF (%) | 58.2 SD 8.1 | 59.5 SD 8.1 | NS | |
|
| ||||
| 150 W | Systolic BP (mmHg) | 185.3 SD 23.4 | 175.8 SD 22.2 | 0.016 |
| Diastolic BP (mmHg) | 93.6 SD 11.6 | 86.4 SD 12.9 | 0.008 | |
| Mean BP (mmHg) | 124.2 SD 13.4 | 116.2 SD 14.1 | 0.003 | |
| Heart rate (bpm) | 124.5 SD 15.8 | 140.2 SD 18.1 | 0.000 | |
| EF (%) | 59.8 SD 8.1 | 61.9 SD 6.6 | NS | |
General echocardiographic characteristics of the study population, P-values were calculated with the Mann-Whitney-U test.
| All subjects ( | |||
|---|---|---|---|
| Hypertensive ( | Control ( |
| |
| Left atrial diameter (cm) | 3.1 SD 0.5 | 2.9 SD 0.5 | 0.022 |
| Interventricular septal diameter, diastolic (cm) | 1 SD 0.2 | 0.9 SD 0.2 | 0.016 |
| Interventricular septal diameter, systolic (cm) | 1.5 SD 0.2 | 1.3 SD 0.2 | 0.020 |
| LV cavity diameter, diastolic (cm) | 5.4 SD 0.5 | 4.3 SD 0.5 | 0.011 |
| LV cavity diameter, systolic (cm) | 3.1 SD 0.5 | 3 SD 0.5 | NS |
| LV posterior wall diameter, diastolic (cm) | 1.1 SD 0.2 | 1 SD 0.2 | NS |
| LV posterior wall diameter, systolic (cm) | 1.5 SD 0.4 | 1.4 SD 0.2 | NS |
| Fractional shortening of the mid-wall (%) | 32 SD 6.6 | 31.3 SD 5.6 | NS |
| Stroke volume (mL) | 57.2 SD 14.5 | 48.3 SD 15 | 0.001 |
| Left ventricular mass (g) | 188.4 SD 59.4 | 148.8 SD 44.2 | 0.001 |
| LV mass/body surface area (g/m2) | 96.8 SD 30.6 | 81.1 SD 21.3 | 0.020 |
| E-Wave/A-Wave | 1.2 SD 0.4 | 1.4 SD 0.5 | NS |
| E-Wave/EI-Wave | 9.3 SD 2.4 | 7.4 SD 1.7 | 0.000 |
| Iso-volumetric contraction time (ms) | 79.6 SD 17 | 72 SD 13.3 | 0.038 |
| Iso-volumetric relaxation time (ms) | 85.5 SD 16.7 | 84.5 SD 13.7 | NS |
Figure 1Tissue-Doppler-derived and speckle-tracking-derived circumferential and longitudinal global strain of hypertensive patients and healthy controls (a) at rest, (b) at 50 Watts resistance, and (c) at 150 Watts resistance during physical stress echocardiography. TDI: tissue-Doppler imaging; STE: speckle-tracking echocardiography; # P < 0.05; * P < 0.001; P values were calculated with the Mann-Whitney-U test and Wilcoxon signed-rank test.
Tissue-doppler: peak LV strain at rest and during stress echocardiography.
| All subjects ( | |||
|---|---|---|---|
| Hypertensive ( | Control ( |
| |
| At rest | |||
| Circumferential | −18.9 SD 2.6 | −22.2 SD 2.1 | <0.001 |
| Longitudinal (2) | −18.3 SD 2.1 | −20.8 SD 2.3 | <0.001 |
| Longitudinal (3) | −17.3 SD 4.1 | −19.2 SD 2.4 | <0.001 |
| Longitudinal (4) | −18.0 SD 2.3 | −20.1 SD 2.3 | <0.001 |
|
| |||
| 50 Watts | |||
| Circumferential | −19.5 SD 3.1 | −23.1 SD 4.4 | <0.001 |
| Longitudinal (2) | −19.1 SD 2.7 | −21.6 SD 2.2 | <0.001 |
| Longitudinal (3) | −17.9 SD 2.3 | −21.1 SD 2.5 | <0.001 |
| Longitudinal (4) | −18.9 SD 2.2 | −21.5 SD 3.0 | <0.001 |
|
| |||
| 150 Watts | |||
| Circumferential | −19.8 SD 3.8 | −23.9 SD 3.6 | <0.001 |
| Longitudinal (2) | −19.4 SD 2.6 | −22.1 SD 2.5 | <0.001 |
| Longitudinal (3) | −18.6 SD 2.0 | −21.8 SD 3.0 | <0.001 |
| Longitudinal (4) | −19.3 SD 2.6 | −22.5 SD 2.9 | <0.001 |
Speckle-tracking: peak LV strain at rest and during stress echocardiography.
| All subjects ( | |||
|---|---|---|---|
| Hypertensive ( | Control ( |
| |
| At rest | |||
| Circumferential | −17.2 SD 3.0 | −19.9 SD 3.7 | 0.001 |
| Longitudinal (2) | −17.6 SD 3.4 | −20.1 SD 3.7 | 0.002 |
| Longitudinal (3) | −17.9 SD 3.4 | −19.8 SD 3.2 | 0.010 |
| Longitudinal (4) | −18.2 SD 3.3 | −19.6 SD 3.0 | 0.014 |
|
| |||
| 50 Watts | |||
| Circumferential | −17.6 SD 4.2 | −21.2 SD 3.4 | <0.001 |
| Longitudinal (2) | −19.3 SD 3.6 | −21.4 SD 3.8 | 0.010 |
| Longitudinal (3) | −19.5 SD 3.5 | −20.9 SD 2.5 | 0.033 |
| Longitudinal (4) | −19.5 SD 2.9 | −21.0 SD 3.1 | 0.011 |
|
| |||
| 150 Watts | |||
| Circumferential | −18.2 SD 4.3 | −22.2 SD 3.6 | <0.001 |
| Longitudinal (2) | −18.6 SD 4.2 | −21.6 SD 4.1 | 0.005 |
| Longitudinal (3) | −18.9 SD 3.4 | −21.0 SD 3.6 | 0.011 |
| Longitudinal (4) | −19.7 SD 3.3 | −20.7 SD 3.4 | NS |
Figure 2Longitudinal strain rate at rest and during physical stress echocardiography in hypertensive patients and healthy controls assessed with tissue-Doppler and speckle-tracking. TDI: tissue-Doppler imaging; STE: speckle-tracking echocardiography; # P < 0.05; * P < 0.001; P values were calculated with the Mann-Whitney U test and Wilcoxon signed-rank test.
Figure 3Speckle-tracking. Longitudinal strain rate at maximal stress during exercise echocardiography (a) in a hypertensive patient and (b) in a healthy control. Note the difference in maximal strain rate during early systole.
Speckle-tracking and tissue-Doppler: Strain rate at rest and during stress testing; P-values are calculated with the Mann-Whitney-U-test.
| Hypertensive ( | Control ( |
| |
|---|---|---|---|
| At rest | |||
| STE (entire septum) | −1.25 SD 0.57 | −1.28 SD 0.21 | 0.037 |
| STE (basal septum) | −1.22 SD 0.42 | −1.17 SD 0.31 | NS |
| TDI (entire septum) | −1.16 SD 0.19 | −1.37 SD 0.27 | <0.001 |
| TDI (basal septum) | −1.24 SD 0.27 | −1.39 SD 0.37 | 0.030 |
|
| |||
| 50 Watts | |||
| STE (entire septum) | −1.65 SD 0.36 | −1.86 SD 0.33 | 0.002 |
| STE (basal septum) | −1.56 SD 0.56 | −1.72 SD 0.49 | NS |
| TDI (entire septum) | −1.55 SD 0.25 | −2.00 SD 0.39 | <0.001 |
| TDI (basal septum) | −1.63 SD 0.30 | −2.06 SD 0.42 | <0.001 |
|
| |||
| 150 Watts | |||
| STE (entire septum) | −1.87 SD 0.37 | −2.35 SD 0.53 | <0.001 |
| STE (basal septum) | −1.93 SD 0.63 | −2.30 SD 0.64 | 0.004 |
| TDI (entire septum) | −1.85 SD 0.30 | −2.42 SD 0.49 | <0.001 |
| TDI (basal septum) | −1.85 SD 0.41 | −2.55 SD 0.65 | <0.001 |